There Will be Blood

The next big medical breakthrough could come from a very unexpected place: the bottom of the sea. It could be the ticket for the biggest, safest biotech gains you’ve ever seen… But it wouldn’t be the first major health breakthrough from the ocean depths. Our subaqueous friends have quietly delivered us a number of life-saving drugs. And countless life-changing profits. Acyclovir You are receiving this email because you subscribed to Outsider Club. [Click here]( to manage your e-mail preferences. [Outsider Club logo] There Will be Blood [Jimmy Mengel Photo] By [Jimmy Mengel]( Written Oct. 18, 2018 The next big medical breakthrough could come from a very unexpected place: the bottom of the sea. It could be the ticket for the biggest, safest biotech gains you’ve ever seen… But it wouldn’t be the first major health breakthrough from the ocean depths. Our subaqueous friends have quietly delivered us a number of life-saving drugs. And countless life-changing profits. Acyclovir — a drug that fights HIV — was born from the Cryptotheca crypta, a sea sponge mostly located in the depths of the Caribbean. *Courtesy of the Smithsonian Ocean Portal Exposed: Video reveals evidence of Amazon’s plan to create its own crypto coin Silicon Valley tech guru recently uncovered what he believes is going to be the biggest profit opportunity in 2018... He says, “I have evidence that Amazon may be on the verge of launching its own … and I’ve found a backdoor cryptocurrency way to rake in massive profits as soon as Amazon makes this huge announcement.” [Watch this must-see video here.]( This strange creature held two amazing chemicals: spongothymidine and spongouridine. These two chemicals were used to develop the first marine-based drug in 1969 — an anti-leukemia drug. It also played a part in the very first HIV drug, which was released in the late 80s. According to David Newman, a chemist at the U.S. National Cancer Institute, “These are arguably the first marine drugs.” HIV drugs are expected to hit $26 billion by 2022. Prialt is a current treatment for chronic pain. It is based on venom from a species of Pacific cone snail — or Conus Magnus (The Magical Cone). This tiny creature is deadly; they have killed dozens of people with their spiny little stingers. Those stingers contain toxins that have been transformed into Ziconotide, a substance said to be 1,000 times more powerful than morphine…"magic cone" indeed. Not only is it more effective, but it also doesn’t have the same addictive qualities as opioids like morphine. The chronic pain industry is projected to hit $83 billion by 2024. Even recognizable creatures, like the seahorse, are used to treat aliments as serious as kidney disease. Every year, over 20 million seahorses are caught and harvested to treat disease. [TMM - Triple Threat 2017 - ad %234 - 11.28.17]( I could go on about the quiet powers of the sea and their unsung value to modern medicine. But I’m here to talk about one ancient creature that could dwarf all of these discoveries… If you've been to the beach on the East Coast, you've seen one of these bad boys... It's the humble horseshoe crab... I remember the first time I saw one flipped upside down in Ocean City, Maryland. I thought I stumbled upon an alien landing. I flipped it back over and sent him back into the sea. But I was still weirded out... Horseshoe crabs are still considered "living fossils" since they've been around for some 450 million years; a pretty good run if you ask me. But creatures don't hang around that long if they aren't valuable in some way. They’re ancient, they're hideous, and almost no one (outside some Asian countries) wants to eat them. But despite all of that, the entirety of [modern medical practices is hopelessly dependent on them](. Therefore, so are we. All of us. Just about the only reason there is such a low risk of infection whenever you get a shot, have surgery, or have a wound treated is because of their blood. Unlike mammals, who use iron-based hemoglobin — or red blood cells — to transport oxygen to our cells, horseshoe crabs use hemocyanin in a semi-closed circulatory system. In other words, they use copper in a circulatory system that would probably lead to all of us hemoglobin users dying of terrible blood-borne infections. Horseshoe crabs can pull this off by producing remarkable biochemicals called amebocytes that function as a powerful antibacterial immune system. Think of conditions like pneumonia, E. coli, and virtually all of the bacteria developing strong multi-drug resistances. The weird just keeps piling up here, too. These cells move themselves around like amoeba, using arm-like extensions of the cell to drag themselves around within the horseshoe crab. By capturing and harvesting this blood and isolating the amebocytes, companies can produce Limulus amebocyte lysate (LAL). This "blue blood" is worth an astounding $60,000 a gallon. That's because any medical device that comes into contact with the inside of your body or your blood has been screened for dangerous infectious diseases with LAL. 90% of FDA-approved drugs require such testing... In the U.S. alone, the medical device market is worth $148 billion and this figure is expected to grow to $173 billion over the next year. Prescription drugs are an even bigger business. Spending in that sector jumped 12% in 2015, reaching a record $425 billion for the year... and this figure is expected to push $610 billion over the next year or so. "Blue blood" will be in heavy demand... One company has completely cornered the market on LAL. It could quietly become the biggest biotech stock story of the next decade. [You need to see this to believe it...]( Godspeed, [Jimmy Mengel] Jimmy Mengel [follow basic]( [@mengeled on Twitter]( Jimmy is a managing editor for [Outsider Club]( and the investment director of the personal finance advisory, [The Crow's Nest,](and cannabis stocks advisory, [The Marijuana Manifesto.]( For more on Jimmy, check out his editor's [page](. *Follow Outsider Club on [Facebook]( and [Twitter](. [Revealed: 27 agencies ready to send you a paycheck like this...]( - $2,157 paid monthly to Bernard G. - $2,686 paid monthly to Paul S. - $3,745 paid monthly to John H. - $3,319 paid monthly to Michael C. - $4,526 paid monthly to Robert S. - $____ paid monthly to YOU! The next batch of checks will be cut in 30 days. To begin receiving stacks of checks like this, you must apply at one of 27 little-known retirement income agencies. The only book in the world that shows you how is "The Big Black Book of Income." We’ll soon sell it for $39.95. However, we’re practically giving away preview copies to the next 199 people. [If you want a copy, click here now.]( Enjoy reading this article? [Click here]( to like it and receive similar articles to read! Browse Our Archives [Is King Canopy Wearing Any Clothes?]( [Underlying Trends Point To A Clear Winner]( [Money Flows and Miners]( [This Is the Way Bear Markets Work]( [Currency Crashes Portend Dark Days Ahead]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Outsider Club, please add newsletter@outsiderclub.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. [Outsider Club](, Copyright © 2018, [Angel Publishing LLC]( & Outsider Club LLC, 111 Market Place #720, Baltimore, MD 21202. For Customer Service, please call (877) 303-4529. All rights reserved. [View our privacy policy here.]( No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. Angel Publishing and Outsider Club does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question. This letter is not intended to meet your specific individual investment needs and it is not tailored to your personal financial situation. Nothing contained herein constitutes, is intended, or deemed to be – either implied or otherwise – investment advice. Neither the publisher nor the editors are registered investment advisors. This letter reflects the personal views and opinions of Nick Hodge and that is all it purports to be. While the information herein is believed to be accurate and reliable it is not guaranteed or implied to be so. Neither Nick Hodge, nor anyone else, accepts any responsibility, or assumes any liability, whatsoever, for any direct, indirect or consequential loss arising from the use of the information in this letter. The information contained herein is subject to change without notice, may become outdated and may not be updated. Nick Hodge, entities that he controls, family, friends, employees, associates, and others may have positions in securities mentioned, or discussed, in this letter. No part of this letter/article may be reproduced, copied, emailed, faxed, or distributed (in any form) without the express written permission of Nick Hodge or the Outsider Club. Unauthorized reproduction of this newsletter or its contents by Xerography, facsimile, or any other means is illegal and punishable by law.